Association of perioperative adverse events with subsequent therapy and overall survival in patients with WHO grade III and IV gliomas.

Publikation

Association of perioperative adverse events with subsequent therapy and overall survival in patients with WHO grade III and IV gliomas.

Wissenschaftlicher Artikel/Review - 28.09.2022

Weber Lorenz, Padevit Luis, Müller Timothy, Velz Julia, Vasella Flavio, Voglis Stefanos, Gramatzki Dorothee, Weller Michael, Regli Luca, Sarnthein Johannes, Neidert Marian Christoph

Zitation

Weber L, Padevit L, Müller T, Velz J, Vasella F, Voglis S, Gramatzki D, Weller M, Regli L, Sarnthein J, Neidert M. Association of perioperative adverse events with subsequent therapy and overall survival in patients with WHO grade III and IV gliomas. Front Oncol 2022; 12:959072.

Art

Wissenschaftlicher Artikel/Review (Englisch)

Zeitschrift

Front Oncol 2022; 12

Veröffentlichungsdatum

28.09.2022

ISSN (Druck)

2234-943X

Seiten

959072

Kurzbeschreibung/Zielsetzung

Maximum safe resection followed by chemoradiotherapy as current standard of care for WHO grade III and IV gliomas can be influenced by the occurrence of perioperative adverse events (AE). The aim of this study was to determine the association of AE with the timing and choice of subsequent treatments as well as with overall survival (OS).